The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Abstract
Cells from some tumors use an altered metabolic pattern compared with that of normal differentiated adult cells in the body. Tumor cells take up much more glucose and mainly process it through aerobic glycolysis, producing large quantities of secreted lactate with a lower use of oxidative phosphorylation that would generate more adenosine triphosphate (ATP), water, and carbon dioxide. This is the Warburg effect, which provides substrates for cell growth and division and free energy (ATP) from enhanced glucose use. This metabolic switch places the emphasis on producing intermediates for cell growth and division, and it is regulated by both oncogenes and tumor suppressor genes in a number of key cancer-producing pathways. Blocking these metabolic pathways or restoring these altered pathways could lead to a new approach in cancer treatments.
Get full access to this article
View all available purchase options and get full access to this article.
References
1
Warburg O., Posener K., Negelein E., Biochem. Z. 152, 309 (1924).
2
Warburg O., On the origin of cancer cells. Science 123, 309 (1956).
3
Hsu P. P., Sabatini D. M., Cancer cell metabolism: Warburg and beyond. Cell 134, 703 (2008).
4
Kroemer G., Pouyssegur J., Tumor cell metabolism: Cancer’s Achilles’ heel. Cancer Cell 13, 472 (2008).
5
Vander Heiden M. G., Cantley L. C., Thompson C. B., Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324, 1029 (2009).
6
Deberardinis R. J., Sayed N., Ditsworth D., Thompson C. B., Brick by brick: Metabolism and tumor cell growth. Curr. Opin. Genet. Dev. 18, 54 (2008).
7
Locasale J. W., Cantley L. C., Vander Heiden M. G., Cancer’s insatiable appetite. Nat. Biotechnol. 27, 916 (2009).
8
Tennant D. A., Durán R. V., Boulahbel H., Gottlieb E., Metabolic transformation in cancer. Carcinogenesis 30, 1269 (2009).
9
E. Gottlieb, K. H. Vousden, in The p53 Family, A. J. Levine, D. Lane, Eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2010), pp. 187–198.
10
Hunt T. K., et al., Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms. Antioxid. Redox Signal. 9, 1115 (2007).
11
Christofk H. R., Vander Heiden M. G., Wu N., Asara J. M., Cantley L. C., Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452, 181 (2008).
12
Semenza G. L., Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721 (2003).
13
Macheda M. L., Rogers S., Best J. D., Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell. Physiol. 202, 654 (2005).
14
Bruick R. K., McKnight S. L., A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337 (2001); 10.1126/science.1066373.
15
Hewitson K. S., McNeill L. A., Elkins J. M., Schofield C. J., The role of iron and 2-oxoglutarate oxygenases in signalling. Biochem. Soc. Trans. 31, 510 (2003).
16
Maxwell P. H., et al., The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271 (1999).
17
DeBerardinis R. J., et al., Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. U.S.A. 104, 19345 (2007).
18
Dang C. V., c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19, 1 (1999).
19
Bensaad K., et al., TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126, 107 (2006).
20
Matoba S., et al., p53 regulates mitochondrial respiration. Science 312, 1650 (2006); 10.1126/science.1126863.
21
Budanov A. V., Sablina A. A., Feinstein E., Koonin E. V., Chumakov P. M., Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304, 596 (2004).
22
Hu W., et al., Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc. Natl. Acad. Sci. U.S.A. 107, 7455 (2010).
23
Suzuki S., et al., Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 107, 7461 (2010).
24
Feng Z., et al., The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 67, 3043 (2007).
25
Z. Feng, in The p53 Family, A. J. Levine, D. Lane, Eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2010), pp. 199–298.
26
Budanov A. V., Karin M., p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134, 451 (2008).
27
Feng Z., Zhang H., Levine A. J., Jin S., The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl. Acad. Sci. U.S.A. 102, 8204 (2005).
28
Parsons D. W., et al., An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807 (2008); 10.1126/science.1164382.
29
Yan H., et al., IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 19, 765 (2009).
30
Ward P. S., et al., The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 16, 225 (2010).
31
Kranendijk M., et al., IDH2 mutations in patients with D-2-hydroxyglutaric aciduria. Science 330, 336 (2010); 10.1126/science.1192632.
32
Dang L., et al., Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 17, 966 (2010).
33
Evans J. M., Donnelly L. A., Emslie-Smith A. M., Alessi D. R., Morris A. D., Metformin and reduced risk of cancer in diabetic patients. BMJ 330, 1304 (2005).
34
Jiralerspong S., et al., Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J. Clin. Oncol. 27, 3297 (2009).
35
Buzzai M., et al., Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res. 67, 6745 (2007).
36
Bourdon A., et al., Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat. Genet. 39, 776 (2007).
37
Minamino T., et al., A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat. Med. 15, 1082 (2009).
38
Kim R. H., et al., DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 7, 263 (2005).
39
Ak P., Levine A. J., p53 and NF-κB: Different strategies for responding to stress lead to a functional antagonism. FASEB J. 24, 3643 (2010).
(0)eLetters
eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.
Log In to Submit a ResponseNo eLetters have been published for this article yet.
Information & Authors
Information
Published In
Science
Volume 330 | Issue 6009
3 December 2010
3 December 2010
Copyright
Copyright © 2010, American Association for the Advancement of Science.
Submission history
Published in print: 3 December 2010
Authors
Metrics & Citations
Metrics
Article Usage
Altmetrics
Citations
Cite as
- Arnold J. Levine,
- Anna M. Puzio-Kuter
Export citation
Select the format you want to export the citation of this publication.
Cited by
- Mushroom-Derived Compounds as Metabolic Modulators in Cancer, Molecules, 28, 3, (1441), (2023).https://doi.org/10.3390/molecules28031441
- Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma, International Journal of Molecular Sciences, 24, 6, (5493), (2023).https://doi.org/10.3390/ijms24065493
- Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles?, International Journal of Molecular Sciences, 24, 5, (4883), (2023).https://doi.org/10.3390/ijms24054883
- Glycolysis Inhibition of Autophagy Drives Malignancy in Ovarian Cancer: Exacerbation by IL-6 and Attenuation by Resveratrol, International Journal of Molecular Sciences, 24, 2, (1723), (2023).https://doi.org/10.3390/ijms24021723
- Mint3 as a Potential Target for Cooling Down HIF-1α-Mediated Inflammation and Cancer Aggressiveness, Biomedicines, 11, 2, (549), (2023).https://doi.org/10.3390/biomedicines11020549
- Biosynthesis of anticancer phytochemical compounds and their chemistry, Frontiers in Pharmacology, 14, (2023).https://doi.org/10.3389/fphar.2023.1136779
- Direct mass spectrometry analysis of biological tissue for diagnosis of thyroid cancer using wooden-tip electrospray ionization, Frontiers in Chemistry, 11, (2023).https://doi.org/10.3389/fchem.2023.1134948
- METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53‐wild‐type cells , EMBO reports, 24, 4, (2023).https://doi.org/10.15252/embr.202256325
- Kinase Suppressor of Ras 2 (KSR2) Regulates Tumor Cell Transformation via AMPK, Molecular and Cellular Biology, 32, 18, (3718-3731), (2023).https://doi.org/10.1128/MCB.06754-11
- Glucose Oxidation Modulates Anoikis and Tumor Metastasis, Molecular and Cellular Biology, 32, 10, (1893-1907), (2023).https://doi.org/10.1128/MCB.06248-11
- See more
Loading...
View Options
Check Access
Log in to view the full text
AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.
- Become a AAAS Member
- Activate your AAAS ID
- Purchase Access to Other Journals in the Science Family
- Account Help
Log in via OpenAthens.
Log in via Shibboleth.
More options
Register for free to read this article
As a service to the community, this article is available for free. Login or register for free to read this article.
Buy a single issue of Science for just $15 USD.